Jessica Nicole Cruz Mora

Ms. Jessica Nicole Cruz Mora

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2025
Verified
Journal Article
Open access
LELakshmi Sowmya Emani
Lakshmi Sowmya Emani
JRJayanth K Rao
Jayanth K Rao
JDJagadeesha Kumar Dasappa
Jagadeesha Kumar Dasappa
MPMarisín Pecchio
Marisín Pecchio
JLJohant Lakey-Beitia
Johant Lakey-Beitia
Rao KosagisharafRao Kosagisharaf
Rao Kosagisharaf
α-synuclein (α-syn) deposition in the mid-brain region is one of the hallmark pathologies of Parkinson's disease (PD). The key steps involve the transformation of α-synuclein into a toxic oligomer and insoluble fibrillar aggregates. To understand the role of curcumin-glucoside in the prevention of α-syn aggregation, a mechanistic approach. In the present study, we synthesized a novel molecule, curcumin-glucoside (Curc-gluc), to improve the water solubility and partition coefficient, making the molecule with high bioavailability. The present study is focused on understanding the α-syn aggregation kinetics in the presence and absence of Curc-gluc, curcumin (Cur), copper (Cu), and iron (Fe) through Thioflavin T analysis, circular dichroism (CD), mathematical approach by self-association kinetics, and molecular docking models. The results indicated that Curc-gluc potentially prevented synuclein aggregation compared to Curc alone and inhibited Cu and Fe-induced synuclein aggregation. CD studies indicated that Curc-gluc favored α-helix formation. The docking studies indicated that Curc-gluc derivatives interacted with various chains of α-syn fibrils, namely G-chain, A-chain, I-Chain, and E-chain and the Pi-Pi interaction indicate that, Curc-gluc shows the most favorable binding affinity with the α-syn fibrils with 60.7222 kcal/mol of -CDOCKER_ ENERGY and 89.6516 kcal/mol of -CDOCKER INTERACTION_ ENERGY. The Absorption, Distribution, Metabolism, Excretion (ADME) analysis indicated that Curc-mono and di-gluc have the highest solubility, bioavailability, and tissue distribution compared to Curc alone. The studies indicated that Curc-gluc prevented α-syn aggregation by favoring α-helix, binding to α-syn, and preventing aggregation, and had high bioavailability.

26 November 2024 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
AOAdrian L Orjuela
Adrian L Orjuela
MPMarisín Pecchio
Marisín Pecchio
Jessica Nicole Cruz MoraJessica Nicole Cruz Mora
Jessica Nicole Cruz Mora
LELakshmi Sowmya Emani
Lakshmi Sowmya Emani
MCMaria Beatriz Carreira
Maria Beatriz Carreira
JLJohant Lakey-Beitia
Johant Lakey-Beitia
Background: Carotenoids, potent antioxidants in fruits and vegetables, have recently garnered attention for their potential therapeutic effects against neurodegenerative diseases. This study focuses on the interaction and anti-aggregation properties of conventional and unconventional carotenoids found in red mamey fruit, a nutraceutical fruit that is a rich source of these compounds. Objective: To assess computational the interaction between of amyloid-β (Aβ) peptide with a set of carotenoids and three carotenoids previously explored in experimental assays as well as to assess ADMET prediction of carotenoids selected by computational analysis results. Methods: We analyzed the interaction between these carotenoids and Aβ peptides using molecular docking, a key factor in Alzheimer's disease (AD) pathology. Selected carotenoids were compared with the reference compounds cryptocapsin ( 1 ), zeaxanthin ( 2 ), lutein ( 3 ), and cryptocapsin-5,6-epoxide ( 24 ), which previously demonstrated significant anti-aggregation activity against Aβ. Using SwissADME and ADMET Predictor ® software to determine the pharmaceutical analysis prediction. Results: Computational analysis identified (5R,8R)-sapotexanthin-5,8-epoxide ( 19 ) and (5S,8S)-cryptocapsin-5,8-epoxide ( 26 ) as the most promising candidates due to their strong binding affinity and potential anti-aggregation properties against Aβ. The pharmaceutical analysis identified compounds (5S,8S)-cryptocapsin-5,8-epoxide ( 26 ) and (5R,8R)-cryptocapsin-5,8-epoxide ( 28 ) as the most promising compounds. Our findings suggest that specific modifications in the carotenoid structure, particularly modifications in the type of epoxidation and stereochemistry, can significantly influence the biological activity of carotenoids and biopharmaceutical performance. Conclusions: These results provide valuable insights for future in vitro studies of most potential carotenoids (19 and 26) and the development of potential therapeutic agents for AD.

25 July 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LCLorena Coronado
Lorena Coronado
JLJohant Lakey-Beitia
Johant Lakey-Beitia
MPMarisín Pecchio
Marisín Pecchio
MNMichelle Ng
Michelle Ng
RCRicardo Correa
Ricardo Correa
CSCarmenza Spadafora
Carmenza Spadafora
Background/Objectives: Curcumin is a promising therapy for glioblastoma but is limited by poor water solubility, rapid metabolism, and low blood–brain barrier penetration. This study aimed to evaluate curcumin and six curcumin derivatives with improved activity against a glioblastoma cell line and favorable absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties. Methods: Twenty-one curcumin derivatives were assessed and subjected to in vitro MTT cytotoxicity assays in SF268 glioblastoma and Vero cells. On the basis of the cytotoxicity results, six derivatives with the most favorable characteristics were selected for additional mechanistic studies, which included microtubule depolymerization, mitochondrial membrane potential (ΔΨm), and BAX activation assays. ADMET properties were determined in silico. Results: Compounds 2–4, 6, and 11 demonstrated better activity (IC50: 0.59–3.97 µg/mL and SI: 3–20) than curcumin (IC50: 6.3 µg/mL; SI: 2.5). Lead derivatives destabilized microtubules, induced ΔΨm collapse, and activated BAX. In silico ADMET prediction analysis revealed that compounds 4 and 6 were the most promising for oral administration from a biopharmaceutical and pharmacokinetic point of view. Conclusions: Strategic modifications were made to one or both hydroxyl groups of the aromatic rings of curcumin to increase its physicochemical stability and activity against glioblastoma cell line SF268. Compound 4, bearing fully protected aromatic domains, was identified as a prime candidate for in vivo validation and formulation development.